Health Dictionary Find a Doctor

Toxic multinodular goiter surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Furqan M M. M.B.B.S[2],Sunny Kumar MD [3]

Overview

Overview

Surgery is the mainstay of treatment for toxic multinodular goiter. Almost all multinodular goiters can be surgically removed through a collar incision. Usually, subtotal thyroidectomy is performed but unilateral thyroid lobectomy can also be performed in selected cases.

Surgery

Surgery

Surgery is the mainstay of treatment for toxic multinodular goiter.[1][2][3][4][5][6]

Indications

Indications of surgery for multinodular goiter (MNG) includes:

Surgical procedures

Almost all multinodular goiters can be surgically removed through a collar incision. An additional thoracotomy is very rarely necessary.

  • If surgery is chosen as treatment for TMNG or TA, patients with overt hyperthyroidism should be rendered euthyroid prior to the procedure with MMI pretreatment, with or without betaadrenergic blockade. Preoperative iodine should not be used in this setting.[1]

Total thyroidectomy

Benefits of total thyroidectomy include:[7]

  • Adequate removal of the diseased gland
  • Prevention of recurrence
  • Avoidance of completion surgery in case of malignancy

Subtotal thyroidectomy

Bilateral subtotal thyroidectomy includes total lobectomy on the dominant lobe and subtotal lobectomy on the contralateral lobe. Bilateral subtotal thyroidectomy is effective in the treatment of multinodular goiter (with hot or cold nodules).[7]
Benefits of Subtotal thyroidectomy:

Unilateral Lobectomy

A unilateral thyroid lobectomy may be performed if only one thyroid lobe is enlarged.

Side effects of surgery

The side effects associated with thyroidectomy include:[8][9][10]

Radioactive iodine therapy

The indications of radioactive iodine therapy includes:

  • Advanced patient age
  • Significant comorbidity
  • Prior surgery or scarring in the anterior neck
  • Small goiter size
References

References

  1. 1.0 1.1 Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, Rivkees SA, Samuels M, Sosa JA, Stan MN, Walter MA (2016). “2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis”. Thyroid. 26 (10): 1343–1421. doi:10.1089/thy.2016.0229. PMID 27521067.
  2. Hurley DL, Gharib H (1996). “Evaluation and management of multinodular goiter”. Otolaryngol. Clin. North Am. 29 (4): 527–40. PMID 8844728.
  3. “www.bprcem.com”.
  4. “Thyroid nodules: pathogenesis, diagnosis and treatment – Best Practice & Research Clinical Endocrinology & Metabolism”.
  5. Moalem J, Suh I, Duh QY (2008). “Treatment and prevention of recurrence of multinodular goiter: an evidence-based review of the literature”. World J Surg. 32 (7): 1301–12. doi:10.1007/s00268-008-9477-0. PMID 18305998.
  6. 7.0 7.1 “Comparison of the Complications of Subtotal, Near Total and Total Thyroidectomy in the Surgical Management of Multinodular Goitre”.
  7. Pelizzo MR, Bernante P, Toniato A, Fassina A (1997). “Frequency of thyroid carcinoma in a recent series of 539 consecutive thyroidectomies for multinodular goiter”. Tumori. 83 (3): 653–5. PMID 9267482.
  8. “Complications after Total ThyroidectomyOtolaryngology-Head and Neck Surgery – Larry J. Shemen, Elliot W. Strong, 1989”.
  9. “Morphological and functional polymorphism within clonal thyroid nodules | The Journal of Clinical Endocrinology & Metabolism | Oxford Academic”.

Template:WH Template:WS

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH